Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 • 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

May 26, 2020 • 00:27:09
Episode Cover

HFNC in COVID-19 Patients - Helpful or Harmful?

As we gain more experience managing critically ill patients with COVID-19 infection there has been a shift away from immediate intubation and towards more...

Listen

Episode

October 15, 2025 • 00:34:24
Episode Cover

Critical Issues in ED Intubation

Emergency physicians intubate critically ill patients daily.  Unfortunately, up to 17% of ED intubations can be complicated by peri-intubation hypoxemia, hypotension, and cardiac arrest....

Listen

Episode 0

July 16, 2021 • 00:22:20
Episode Cover

The ED-AWARENESS Study

Ventilated ED patients may be at high risk for awareness with paralysis, thereby increasing the risk of long-term psychological sequelae.  In this podcast, we...

Listen